Table 4 Univariate and multivariate analyses to determine the risk factor for ESCC recurrence
Recurrence-free survival | |||
|---|---|---|---|
Univariate | Multivariate | ||
Characteristic | p value | HR (95 % CI) | p value |
Positive CXCL12 expression (+/−) | 0.021 | 5.12 (1.54–17.01) | 0.008 |
Positive CXCR4 expression (+/−) | 0.97 | ||
pT (≥pT3 vs < pT3) | 0.10 | ||
Lymph node metastasis (+/−) | 0.005 | ||
Lymphatic invasion (+/−) | 0.002 | 1.84 (1.24–2.72) | 0.002 |
Vessel invasion (+/−) | 0.004 | 2.13 (1.03–4.39) | 0.04 |